4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000899243-23-010815
Chief Financial Officer sold 4,640 shares at an average $29.74 ($137,978)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Burrell Terry-Ann Chief Financial Officer | 2023-04-03 | Sale 10b5-1 | −2,454 | $30.31 | $74,381 | 49,303 | D |
| Burrell Terry-Ann Chief Financial Officer | 2023-04-04 | Sale 10b5-1 | −2,186 | $29.09 | $63,598 | 47,117 | D |
| Open-market sales · 4,640 sh · avg $29.74 · $137,978 | |||||||
Loading xslF345X04/doc4.xml…